BSEShelter Pharma LtdMediumNeutral
Announced Thu, 29 May · 13:17 IST

Appointment of Secretarial Auditor for the period of 5 years

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Shelter Pharma Limited's Board of Directors, at a meeting held on 29th May 2025, approved the reappointment of M/s. Murtuza Mandorwala & Associates, Practicing Company Secretaries, as the company's Secretarial Auditor. The reappointment is for a period of five years, covering FY 2025-26 to FY 2029-30, to comply with Section 204 of the Companies Act, 2013 and SEBI Listing Regulations. The firm is based in Ahmedabad, is a member of the Institute of Company Secretaries of India, and holds a valid peer-review certificate. The Managing Director, Mustaqim Nisarahmed Sabugar, signed the intimation filed with BSE.

Likely market impact

This is a routine regulatory compliance announcement with no material impact on shareholders or stock price. It confirms continuity of the company's secretarial audit function for the next five years.